Nexalin Technology (NXL) Expected to Announce Quarterly Earnings on Wednesday

Nexalin Technology (NASDAQ:NXL) will likely be posting its results before the market opens on Wednesday, June 3rd. Analysts expect Nexalin Technology to post earnings of ($0.10) per share and revenue of $0.0150 million for the quarter.

Nexalin Technology (NASDAQ:NXL) last announced its quarterly earnings results on Friday, May 8th. The company reported ($0.11) EPS for the quarter, missing the consensus estimate of ($0.10) by ($0.01). Nexalin Technology had a negative return on equity of 191.88% and a negative net margin of 3,018.12%.The business had revenue of $0.01 million for the quarter, compared to analyst estimates of $0.02 million.

Nexalin Technology Stock Up 27.1%

Shares of NXL opened at $0.48 on Wednesday. Nexalin Technology has a 12 month low of $0.31 and a 12 month high of $2.00. The company’s fifty day moving average is $0.39 and its 200-day moving average is $0.61. The firm has a market cap of $9.88 million, a price-to-earnings ratio of -1.02 and a beta of 3.56.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently bought and sold shares of the company. Susquehanna International Group LLP acquired a new position in Nexalin Technology in the 3rd quarter valued at $57,000. Renaissance Technologies LLC grew its stake in Nexalin Technology by 119.2% in the 4th quarter. Renaissance Technologies LLC now owns 122,100 shares of the company’s stock valued at $68,000 after buying an additional 66,400 shares during the last quarter. Geode Capital Management LLC grew its stake in Nexalin Technology by 23.4% in the 4th quarter. Geode Capital Management LLC now owns 150,274 shares of the company’s stock valued at $84,000 after buying an additional 28,454 shares during the last quarter. Finally, PEAK6 LLC acquired a new position in Nexalin Technology in the 4th quarter valued at $266,000. 0.65% of the stock is currently owned by institutional investors and hedge funds.

Nexalin Technology Company Profile

Nexalin Technology, Inc is a U.S.-based medical device company specializing in noninvasive neuromodulation therapies for mental health conditions. The company develops and markets the Nexalin® medical device platform, which delivers proprietary alternating current waveforms to targeted areas of the brain through forehead-mounted electrodes. Its technology is designed to modulate neural activity without pharmaceuticals, positioning the company within the growing field of digital therapeutics and neurostimulation.

The Nexalin device has received U.S.